Content about Antibiotic resistance

January 10, 2013
Study: Misconceptions about antibiotics linked to poor health literacy levels in Latino population

A recent study found that poor heath literacy among Latino parents is associated with incorrect beliefs on the proper use of antibiotics, particularly for upper respiratory infections, which can lead to an increase in antimicrobial resistance.

NEW YORK — A recent study found that poor heath literacy among Latino parents is associated with incorrect beliefs on the proper use of antibiotics, particularly for upper respiratory infections, which can lead to an increase in antimicrobial resistance.

September 24, 2012
FDA creates antibiotic development task force

The Food and Drug Administration is creating a new task force to support the development of new drugs for bacterial infections, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration is creating a new task force to support the development of new drugs for bacterial infections, the agency said Monday.

The FDA said the Antibacterial Drug Development Task Force would assist in developing and revising guidance related to development of antibiotics, as required by the Generating Antibiotic Incentives Now Title of the FDA Safety and Innovation Act, which president Barack Obama signed into law on July 9.

September 10, 2012
AstraZeneca, Broad Institute partner on antibiotic, antiviral drugs

A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

CAMBRIDGE, Mass. — A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

AstraZeneca and the Broad Institute, owned jointly by Harvard University and MIT, announced Monday that they would collaborate for two years to develop medicines to treat severe infections, saying the identification of high-quality chemicals for the development of new drugs was a significant challenge. The two will use the Broad Institute's collection of 100,000 chemicals known as diversity-oriented synthesis, or DOS compounds.

September 14, 2011
Study: Antimicrobial-resistant MRSA revealed; may reverse infection decline

A new resistant strain of methicillin-resistant staphylococcus aureus may be on the rise due to the frequent use of over-the-counter antibacterial ointments, according to a study to be published in the October issue of Emerging Infectious Diseases.

ATLANTA — A new resistant strain of methicillin-resistant staphylococcus aureus may be on the rise due to the frequent use of over-the-counter antibacterial ointments, according to a study to be published in the October issue of Emerging Infectious Diseases.

As reported by CNN.com, Japanese researchers made the finding after testing 259 MRSA strains for susceptibility to bacitracin and neomycin, two of the antibacterial ingredients commonly found in such OTC ointments as Neosporin and Polysporin.

April 21, 2011
FDA warns companies to stop making MRSA claims for over-the-counter products

The Food and Drug Administration on Wednesday issued four warning letters to companies that manufacture and market over-the-counter drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria, or MRSA.

SILVER SPRING, Md. — The Food and Drug Administration on Wednesday issued four warning letters to companies that manufacture and market over-the-counter drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria, or MRSA.

March 10, 2011
N.Y. congresswoman introduces Preservation of Antibiotics for Medical Treatment Act

A lawmaker from New York has introduced legislation designed to combat the rise of antibiotic-resistant bacteria.

WASHINGTON — A lawmaker from New York has introduced legislation designed to combat the rise of antibiotic-resistant bacteria.

Keep Antibiotics Working, a Chicago-based organization, praised the Preservation of Antibiotics for Medical Treatment Act, introduced by Rep. Louise Slaughter, D-N.Y.

October 31, 2010
FDA approves new treatment for bacterial infections

The Food and Drug Administration has approved a new treatment for bacterial infections made by...

NEW YORK The Food and Drug Administration has approved a new treatment for bacterial infections made by Forest Labs, Forest said.

The drug maker announced the approval of Teflaro (ceftaroline fosamil) for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection, also known as ABSSSI, caused by bacteria that include methicillin-resistant Staphylococcus aureaus.